Hemolytic Uremic Syndrome
Hemolytic Uremic Syndrome - Related Videos
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
0 Views •
Cited by 41 •
2017
This manuscript provides a detailed two-step surgical procedure to perform mouse 5/6th partial nephrectomy (PNx) with pole ligation. Four weeks after surgery, in comparison with sham-operated mice, the PNx mice developed impaired renal function, anemia, cardiac hypertrophy, cardiac fibrosis, and decreased heart systolic and diastolic function.
02:43
Preparing a Hemolytic Staphylococcus aureus Culture for Host-Pathogen Interaction Studies
0 Views •
2026
Source: Behera, R.K. et. al., A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues. J. Vis. Exp. (2019)This video demonstrates the preparation of hemolytic Staphylococcus aureus cultures to standardize bacterial growth and achieve metabolic synchronization for host-pathogen interaction studies.
06:32
Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
0 Views •
2025
Here, we describe the protocols for obtaining primary cultures of human renal tubular epithelial cells (HRTEC) from the kidney cortex to develop monolayers and three-dimensional cultures on an extracellular matrix (3D-HRTEC).
08:31
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
0 Views •
Cited by 5 •
2016
An EEG experimental protocol is designed to clarify the interplay between conscious and non-conscious representations of emotional faces in patients with Asperger's syndrome. The technique suggests that patients with Asperger's syndrome have deficits in non-conscious representation of emotional faces, but have comparable performance in conscious representation with healthy controls.
07:27
Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
0 Views •
2026
Robotic-assisted pneumonectomy is safe and effective in the management of Vanishing Lung Syndrome, with reduced morbidity and faster recovery times.
FAQs
Shiga toxin-producing Escherichia coli can injure endothelial cells, which form the lining of small blood vessels. In the kidneys, this vascular damage promotes platelet consumption and disrupts the microcirculation. The resulting injury helps explain why acute kidney impairment develops alongside microangiopathic hemolytic anemia, linking a microbial product to a systemic vascular and renal outcome.
The two blood abnormalities reflect different consequences of small-vessel injury. Damaged vessels can mechanically contribute to red blood cell destruction, producing microangiopathic hemolytic anemia, while platelets are consumed during the vascular response. Considering these findings together is important because their combination, rather than either abnormality alone, characterizes the disorder's broader disease process.
The kidney is a major site of concern because Shiga toxin-associated endothelial injury particularly affects its small blood vessels. Vascular damage there can impair kidney function while also participating in platelet consumption and red blood cell destruction. This relationship makes HUS a useful biological model for examining how host-pathogen interactions produce organ-specific consequences.
Recognition depends on the characteristic combination of red blood cell destruction, reduced platelet levels, and acute kidney injury, interpreted in the appropriate clinical context. Laboratory and clinical findings that reveal these linked abnormalities support identification of the syndrome. Early recognition matters because it directs attention toward kidney function and complications involving fluids, electrolytes, and blood.
Supportive care centers on monitoring kidney function and responding to complications caused by impaired renal performance and blood abnormalities. Management may require attention to fluid balance, electrolyte disturbances, and blood-related complications. The overview does not specify a single treatment sequence, so care is guided by the patient's evolving kidney and laboratory status.
HUS connects an infectious exposure with endothelial injury, blood-cell changes, and kidney failure, allowing researchers to study host-pathogen interactions across multiple biological levels. It also provides a model for examining vascular injury and the progression of renal dysfunction. These linked outcomes make the syndrome relevant to both microbial biology and the study of organ damage.